GLP1 NAION warning: FDA orders class-wide labels for potential rare eye risk

Points more than one outlet reported

1. FDA requirement for NAION warnings on GLP-1 labels3 outlets
2. NAION effects on vision2 outlets
3. Drugs covered by the FDA labeling requirement2 outlets
4. Evidence included in the FDA evaluation2 outlets